# Phase 8 — Multi-Agent Analyst Desk

**Ticker:** PATH (UiPath Inc.)
**As-of date:** 2026-06-01
**Generated:** 2026-06-01T21:10:00-04:00
**Upstream phases cited:** phase-1 through phase-7c (full chain packed into each agent)

## Summary

The desk is **unanimously non-directional and low-conviction**: of four agents (earnings-
scout skipped — earnings just reported, next 9/3 >30d), **2 returned NEUTRAL and 2 returned
RANGE; zero LONG, zero SHORT; every conviction = 2/5.** Despite the genuine dark-pool
accumulation, the fundamental profitability inflection, and the 31% short-float squeeze
fuel, **no agent would chase a long**; despite the +12% overbought spike into the 200-day
and the target-cutting Street, **no agent would short it**. The convergence is a
defined-risk **$12.89–$15 range with a $13 gamma pin** — sell the wings, do not take a
directional bet. The four lenses cancel into the same box from different angles.

## Agent verdicts table

| Agent | bias | conviction | horizon | one_line_take |
|-------|------|-----------|---------|---------------|
| accumulation-hunter | **NEUTRAL** | 2 | 1-4w | Real buying happened at $12.7 not $13.1 — the move already paid the accumulators; won't chase a stealth build that de-cloaked. |
| contrarian-scanner | **RANGE** | 2 | 1-4w | No clean fade (P/C normal, no divergence); a $12.89–$15 condor, not a short. Don't chase, don't fight the squeeze. |
| sweep-tracker | **NEUTRAL** | 2 | 1-5d | No sweep momentum — loudest aggressor is a hedge, call buying diffuse across 6 expiries; stand aside. |
| risk-monitor | **RANGE** | 2 | 1-4w | Conflicting signals net to a defined-risk range; overbought spike, edge-negative flow, half-size regime — sell the $11/$15 wings. |
| earnings-scout | *SKIPPED* | — | — | Earnings reported 05-29 / next 2026-09-03 (>30d) → out of window. |

**Distribution:** LONG 0 · SHORT 0 · NEUTRAL 2 · RANGE 2. Avg conviction **2.0**.

## Per-agent details

### accumulation-hunter — NEUTRAL (2), 1-4w
- support 12.86 (deeper 11.70/11.28) · resistance 13.00 pin / 15.00 wall · invalidation:
  close <$11.70 voids accumulation thesis; close >$13.50 on volume confirms continuation.
- top_signal: Phase-2 genuine net institutional buying — large-tier buy_ratio 0.634,
  +4.6M sh (~1.1% float), 1.6M-share buy block @ $12.72 ($20.35M, 0.388% float).
- top_risk: Phase-5 MIXED 90d cumulative flow (net +$1.1M/36 sessions) + buys *below* a
  +12% RSI-74 spike → accumulation-into-strength now in profit, not a fresh pre-move build.

### contrarian-scanner — RANGE (2), 1-4w
- support 12.89 (deeper 11.70) · resistance 15.00 (14 first) · invalidation: close >$15
  flips LONG (squeeze breaks pin) OR close <$12.72 on volume flips SHORT toward $11.
- top_signal: Phase-4 LONG-GAMMA POSITIVE (GEX +18.1M, $13 pin), every near-expiry
  max-pain $11, COMPLACENT skew → vol-suppressed mean-reversion box, sell premium inside.
- top_risk: 31% short float (phase-7c) overrides the pin and forces a continuation squeeze
  through $15 — "the crowd I'd fade is the wrong crowd to fade."
- Discipline note: explicitly did NOT issue a short fade — P/C extreme & price-vs-flow
  divergence triggers both stayed silent; only 1 of 5 fade signals fired.

### sweep-tracker — NEUTRAL (2), 1-5d
- support 12.86 ($12.86–12.91 zone) · resistance 14.00 (first wall; $15 major) ·
  invalidation: break+hold <$12.72 (the buy block) flips short; sustained ask-side $13/$14
  near-term call sweeps with no offsetting puts flips long.
- top_signal: Phase-1 — the loudest print is bearish/protective: $2.31M new ATM Sep $13 put
  (vol 10,328/OI 372 = 27.8×), net ask-side, ~36% of the day's bearish premium.
- top_risk: that Sep put is more plausibly a hedge on the 1.6M-share DP accumulation than a
  short → underlying long bias may be stronger than the two-sided tape shows (squeeze miss).

### risk-monitor — RANGE (2), 1-4w
- support 12.86 (VWAP $12.89; then 11.70/11.28) · resistance 15.00 (14 first) ·
  invalidation: close <$11.70 (loses DP support → max-pain $11 gravity) OR close >$15.10 on
  volume (squeeze overrides pin → LONG).
- top_signal: Phase-4 — three independent tools (GEX peak +5.86M, all near-expiry max-pain,
  phase-3 call wall) agree on $13 pin / $11 floor / $15 cap; dealers long gamma (ZGL $8.10
  far below) mechanically suppress vol into a $12–15 chop.
- top_risk: the book is **unhedged into a downside surprise** — COMPLACENT skew + negative
  vanna (falling post-earnings IV → dealer selling) + max-pain $11 (110k OI Jun-18) +
  Street cutting to $13–15 + $35M fund exit; soft easy-borrow (0.29%) 31% short = squeeze
  fuel largely spent → asymmetric tail is a fast mean-revert to $12.89/$11, not a squeeze.
- Risk lens extras: **correlation cluster NONE** (PATH only blueprint); regime TRANSITIONAL
  breadth 40% → size already halved *before* the 7c CAUTION cuts another step; **no sector-
  unwind** vs PATH (Tech flowing IN, +$982M, persistence 1; unwind is in Comm Svcs/Cons
  Cyc/Cons Def). Quantified conflict: bull's two pillars (squeeze, flow) are the *weakest*
  (soft borrow; backtest edge-negative win 44.4%, MIXED 90d), while four bearish/mean-revert
  vectors align — but long-gamma caps the drop speed → RANGE not SHORT.

## Disagreements

No directional disagreement — **no agent took LONG or SHORT.** The only axis of nuance is
NEUTRAL (accumulation-hunter, sweep-tracker: "stand aside, no edge") vs RANGE (contrarian,
risk-monitor: "actively sell the $11/$15 wings"). Both agree the trade is non-directional;
they differ only on whether to *engage* the range (sell premium) or *pass*. Two agents
flag the same tail in opposite directions as their top_risk — sweep-tracker fears missing
the squeeze (long-miss), risk-monitor/contrarian fear the mean-revert to $11 — which is
exactly why the net is a two-sided RANGE.

## Tool errors

- `MISSING/SKIPPED: earnings-scout` — earnings already reported (05-29); next 2026-09-03 is
  >30d out → role not applicable to a post-earnings setup (per phase-8 rule).
- All four active agents read source artifacts and re-ran 1–2 live `uw` checks
  (sector-rotation, market-regime, sweeps) that re-confirmed phases 1–7; no contradictions.

## Verdict for downstream phases

- **Plurality bias:** **RANGE / NEUTRAL** — 4 of 4 non-directional (2 RANGE, 2 NEUTRAL),
  0 LONG, 0 SHORT.
- **Average conviction:** **2.0 / 5** across the four active agents.
- **Three highest-quality signals across agents:**
  1. **Phase-4 structural box** (risk-monitor + contrarian): GEX +18.1M long-gamma, $13 pin,
     max-pain $11, $15 wall — three tools agree on $11/$13/$15; vol-suppressed $12–15 chop.
  2. **Phase-2 accumulation** (accumulation-hunter): large-tier buy_ratio 0.634, +4.6M sh
     (~1.1% float), 1.6M block @ $12.72 — real, but now in profit (de-cloaked).
  3. **Phase-1 hedge tell** (sweep-tracker): the loudest print is the $2.31M ATM Sep $13 put
     (hedge), call buying diffuse → no momentum to chase.
- **Open questions surfaced:**
  1. Does the 31% short squeeze override the $13 pin (>$15 → LONG), or is it spent (easy
     0.29% borrow, +12% already covered)? → phase-8b to debate.
  2. Does post-earnings drift fade toward the $11 max-pain into the **FOMC 6/16–17 / Jun-18
     OPEX** node, or hold the $12.89 VWAP? → phase-8b / phase-9 sizing.
- **Hand to phase-9:** the desk endorses a **defined-risk, premium-selling RANGE structure
  ($11/$12.89 floor — $14/$15 cap) at half-or-less size**, NOT a directional position. This
  aligns with the regime guidance ("iron condors in range") and the premium-selling VRP.
